Leukoreduced blood components: Advantages and strategies for its implementation in developing countries.

Leukoreduced blood components: Advantages and strategies for its implementation in developing countries.

Item
http://www.wikidata.org/entity/Q33760699
Current trends in platelet transfusions practice: The role of ABO-RhD and human leukocyte antigen incompatibilityA high-throughput microfluidic approach for 1000-fold leukocyte reduction of platelet-rich plasmaRelease of cytokines in stored whole blood and red cell concentrate: Effect of leukoreduction.Retrospective evaluation of adverse transfusion reactions following blood product transfusion from a tertiary care hospital: A preliminary step towards hemovigilance.Duration of red blood cell storage and inflammatory marker generationEffects of Prestorage Leukoreduction on the Rate of Febrile Nonhemolytic Transfusion Reactions to Red Blood Cells in a Tertiary Care Hospital.Study of alloimmunization and autoimmunization in Iranian β-thalassemia major patients.Aged Human Stored Red Blood Cell Supernatant Inhibits Macrophage Phagocytosis in an HMGB1 Dependent Manner After Trauma in a Murine Model.Application of reticulated platelets to transfusion management during autologous stem cell transplantation.Microparticle formation in apheresis platelets is not affected by three leukoreduction filters.Leucoreduction helps to preserve activity of antioxidant barrier enzymes in stored red blood cell concentrates.
P2860

Leukoreduced blood components: Advantages and strategies for its implementation in developing countries.

Item
http://www.wikidata.org/entity/Q33760699
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Leukoreduced blood components: ...... ation in developing countries.
@ast
Leukoreduced blood components: ...... ation in developing countries.
@en
type
label
Leukoreduced blood components: ...... ation in developing countries.
@ast
Leukoreduced blood components: ...... ation in developing countries.
@en
prefLabel
Leukoreduced blood components: ...... ation in developing countries.
@ast
Leukoreduced blood components: ...... ation in developing countries.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P932
P356
P1433
P1476
Leukoreduced blood components: ...... ation in developing countries.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P932